Roquette, a producer of plant-based ingredients, pioneer of plant proteins and world-leading provider of pharmaceutical excipients, has announced the launch of its ready-to-use vegetarian softgel capsule technology, Lycagel Premix. Developed using the company’s pea starch technology, Lycagel launched in 2020, while the updated softgel blend provides manufacturers with an easy-to-use version designed to ensure fast and reproducible scale-up for both nutraceutical and pharmaceutical applications.
A complete, plant-based powder, Lycagel Premix is designed to enable capsule characteristics comparable to gelatin softgels, including strength, seal integrity, quick drying time with no stickiness, fast disintegration, and high thermal and chemical stability. Supporting non-GMO, halal, kosher and clean-label claims, the product aims to offer offers manufacturers a delivery platform which eliminates dosing steps.
“Accessing the right quantities of raw materials is not always straightforward. LycagelPremix eliminates the need for manufacturers to manage multiple raw material inventory and simplifies processes, like handling and storage, as well as streamlining manufacturing through the simple addition of water and glycerol to the powder,” said Paul Smaltz, VP of Roquette Pharmaceutical Solutions.
Smaltz adds: “Available as a drop-in solution for customers’ existing systems, it is now easy for manufacturers to adopt the premix into current manufacturing set-ups without requiring re-tooling of the line. This eliminates the need for dosing of individual ingredients, while also minimizing the risk of variability and probability of production failure. We look forward to seeing what the future holds for Lycagel Premix.”
